If you take two different biological age tests, you will likely get two different results. Not because one is wrong, but because they are designed to answer different questions about your biology.
This is the most common source of confusion in the biological age space — and the most important thing to understand before you compare products, interpret results, or track changes over time.
Nearly all aging clocks fall into one of three paradigms. Each measures something real. Each has a different use case.
Paradigm 1: How old does your body look?
The first generation of aging clocks were trained to answer a straightforward question: given your biological data, how old do you appear?
These are sometimes called chronAge clocks or age-prediction clocks. The most well-known are Steve Horvath's pan-tissue clock (2013) and Gregory Hannum's blood-based clock (2013). Both were trained by feeding DNA methylation data from thousands of people into a model alongside their known calendar ages. The model learns which methylation patterns correspond to which ages — and then predicts age for new samples.
When your predicted age deviates from your actual age, researchers call that age acceleration (or deceleration). Someone who is 50 but has a predicted biological age of 55 is considered to be aging faster than average.
The strength of these clocks is precision in age estimation — the Horvath clock predicts chronological age with a median error of about 3.6 years. The limitation is that predicting calendar age well doesn't necessarily mean predicting health outcomes well. A person can look biologically “young” on a chronAge clock while still carrying significant disease risk.
Paradigm 2: What is your health risk?
Second-generation clocks took a different approach. Instead of training on calendar age, they were trained on health outcomes — mortality, disease incidence, or composite health measures.
PhenoAge (Levine, 2018) was trained on a combination of clinical biomarkers known to predict mortality, then mapped back to DNA methylation. GrimAge (Lu, 2019) incorporated smoking history and plasma protein levels into its training, making it one of the strongest predictors of lifespan and healthspan currently available.
These clocks sacrifice some accuracy in age prediction to gain predictive power for what most people actually care about: health and longevity. A person who looks “young” on the Horvath clock but “old” on GrimAge may have chronAge-typical methylation patterns but elevated risk factors that the first-generation clock wasn't designed to detect.
Paradigm 3: How fast are you aging right now?
The newest paradigm doesn't estimate a cumulative biological age at all. Instead, it measures the current rate of aging — how many years of biological wear your body accumulates per calendar year.
DunedinPACE (2022) is the leading example. It was developed from the Dunedin longitudinal study, which tracked the same group of people from birth into middle age, measuring 19 biomarkers repeatedly over two decades. The resulting clock captures the pace of biological change rather than an accumulated state.
A pace of 1.0 means you are aging at the population average. Below 1.0 means slower than average; above 1.0 means faster. DunedinPACE has shown sensitivity to lifestyle interventions in randomized trials — something earlier paradigms have struggled to demonstrate convincingly.
This makes pace-of-aging clocks potentially more useful for tracking the impact of changes you make. But they have a trade-off: they tell you about your current trajectory, not where you stand overall. A person who aged rapidly for a decade but recently slowed down would show a favorable pace — while still carrying the accumulated burden of earlier damage.
Why one person gets different results
This is now easy to understand. A 50-year-old might receive:
- Horvath clock: biological age 47 — their methylation patterns look younger than average.
- GrimAge: biological age 54 — their mortality-linked markers suggest elevated risk.
- DunedinPACE: 0.92 — they are currently aging slower than average.
None of these results contradict each other. Each clock is reading a different dimension of the same biology. The Horvath result says their methylation landscape looks young. GrimAge says their health risk profile looks older. DunedinPACE says their current trajectory is favorable. All three can be simultaneously true.
Which paradigm matters for what
The three paradigms serve different purposes, and matching the right clock type to your goal matters more than picking the one with the most impressive marketing.
Age-prediction clocks are useful as a general benchmark — a reference point for where you stand relative to the population. They are well-validated and widely used in research, but they weren't designed to predict disease or respond sensitively to lifestyle changes.
Health-risk clocks are more clinically informative. If your goal is understanding your risk trajectory — particularly if you have family history of age-related disease or specific health concerns — a GrimAge or PhenoAge result carries more prognostic weight than a Horvath result.
Pace-of-aging clocks are best suited for tracking change over time. If you have made a significant lifestyle intervention and want to see whether it is registering biologically, DunedinPACE is currently the most responsive tool available.
What to ask before you test
Before choosing a biological age test, the most useful question isn't “which test is best?” It's “what do I want to know?”
If you want a baseline snapshot, a chronAge clock gives you a reference point. If you want a health risk assessment, look for a test that includes GrimAge or PhenoAge. If you want to track whether your interventions are working, DunedinPACE is the strongest current option. And if you want the most complete picture, some providers now offer panels that include clocks from more than one paradigm.
Understanding the paradigm behind a clock is the difference between being confused by conflicting results and knowing exactly what each number means.